Approval · Notice of Compliance 336 · 2002
CEFACLOR SUSPENSION: Notice of Compliance 336
Issued December 11, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 336
- Date
- December 11, 2002
- Company
- Ivax Pharmaceuticals IncorporatedToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Manufacturer and product name change
- Therapeutic class
- Antibiotic
- Canadian reference product
- CECLOR (Eli Lilly Canada Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CEFACLOR SUSPENSION | 02238790 | Cancelled Pre Market |
| CEFACLOR SUSPENSION | 02238791 | Cancelled Pre Market |
| CEFACLOR SUSPENSION | 02238792 | Cancelled Pre Market |
| CEFACLOR SUSPENSION | 02238793 | Cancelled Pre Market |